Healthcare companies are in focus as fears rise over the COVID-19 new variant Omicron, which could result in higher revenues being generated due to a rise in testing, treatment and vaccinations.
CNBC-TV18 has the revenue trends of hospital and diagnostic companies in the past few quarters to understand what the impact of the new variant of the virus could be.
Most hospital as of Q2FY22 has seen their COVID-19 revenues dip significantly. The diagnostic companies also saw a steep fall in COVID-19 related testing.
For more watch the video